A12 The SHP2 Inhibitor RMC-4630 in Patients with KRAS-Mutant Non-Small Cell Lung Cancer: Preliminary Evaluation of a First-in-Man Phase 1 Clinical TrialSai‐Hong Ignatius Ou, Trever G. Bivona, Marianna Koczywas et al.|Journal of Thoracic Oncology|2020Cited by 74
Integrated Genomic Characterization of the Human Immunome in CancerYongsheng Li, S. Stephen Yi, Brandon Burgman et al.|Cancer Research|2020Cited by 32
Supplementary Table S5 from Integrated Genomic Characterization of the Human Immunome in CancerYongsheng Li, S. Stephen Yi, Brandon Burgman et al.|Unknown|2023Cited by 0
Supplementary Figures from Integrated Genomic Characterization of the Human Immunome in CancerYongsheng Li, S. Stephen Yi, Brandon Burgman et al.|Unknown|2023Cited by 0
Supplementary Table S2 from Integrated Genomic Characterization of the Human Immunome in CancerYongsheng Li, S. Stephen Yi, Brandon Burgman et al.|Unknown|2023Cited by 0